Form 8-K AUXILIUM PHARMACEUTICALS For: Sep 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Auxilium's (AUXL) Restructuring Seen as Positive by MKM
September 10, 2014 11:44 AM EDTMKM affirms Auxilium (Nasdaq; AUXL) at Buy with a price target of $26 following news that the company plans to reduce annual expenses by at least $75 million and headcount by 30 percent.
MKM noted the following key points:Auxilium's merger with QLT is expected to close by October 31, will significantly... More
